Safety And Immunogenicity Of The Chadox1 Ncov-19 Vaccine Against Sars-Cov-2: A Preliminary Report Of A Phase 1/2, Single-Blind, Randomised Controlled Trial (Vol 396, Pg 467, 2020)

LANCET(2020)

引用 1|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要